Abstract
Background. Quality improvement methodology was used to improve neuropathic pain (NP) screening at a comprehensive cancer center. Methods. Nurses participated in educational sessions about screening and assessment. Clinical systems to facilitate documentation of NP severity scores were developed. Results. Pretest and posttest score results demonstrated nurse acquisition of new knowledge. A 90% NP screening adherence rate was achieved (N=3831). Patients with no reported general pain (n=291) were found to have moderate to severe NP. Conclusions. Keys to success are (1) health care professional education and periodic reinforcement of learning and (2) system infrastructure changes.
Similar content being viewed by others
References
Paice J. Mechanisms and management of neuropathic pain in cancer. Support Oncol. 2003;1: 107–120.
Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–1534.
Bakitas MA. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007;56:323–331.
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the neuropathic pain scale. J Pain. 2005;6:98–106.
Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain—a multidimensional burden for patients. Eur J Pain. 2001;5:379–389.
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–128.
Smith EL, Whedon MB, Bookbinder M. Quality improvement of painful peripheral neuropathy. Semin Oncol Nurs. 2002;18:36–43.
Bakitas MA. Understanding chemotherapy-induced peripheral neuropathy: The patient’s perspective on symptoms and the impact on everyday life. New Haven, CT: Yale University Press; 2006.
Smith EL, Beck SL, Cohen J. The total neuropathy score (TNS): a tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2008;35:96–102.
Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO’s pain standards: an institutional challenge. J Pain Symptom Manage. 2003;25:519–527.
Davis MP, Walsh D. Cancer pain: how to measure the fifth vital sign. Cleve Clin J Med. 2004;71:625–632.
Nelson E, Batalden P, Ryer J, eds. Clinical Improvement Action Guide. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1998.
Rogers E. Diffusion of Innovations. New York, NY: The Free Press; 1995.
Merskey H, Bogduk N. Part III: Pain terms: A current list with definitions and notes on usage. In: Classification of Chronic Pain: IASP Task Force on Taxonomy. 2nd ed. Seattle, WA: IASP Press; 1994;209–214.
Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 1997;48:332–338.
Jensen MP, Friedman M, Bonzo D, Richards P. The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain. 2006;22:97–103.
Jensen MP, Gammaitoni AR, Olaleye DO, Oleka N, Nalamachu SR, Galer BS. The pain quality assessment scale: Assessment of pain quality in carpal tunnel syndrome. J Pain. 2006;7:823–832.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the ONS Foundation Center for Leadership, Information, and Research through an unrestricted grant from Genentech, Inc.
Rights and permissions
About this article
Cite this article
Lavoie Smith, E.M., Bakitas, M.A., Homel, P. et al. Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer. J Canc Educ 24, 135–140 (2009). https://doi.org/10.1080/08858190902854715
Issue Date:
DOI: https://doi.org/10.1080/08858190902854715